These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 10389920

  • 1. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.
    Wymenga AN, van der Graaf WT, Hofstra LS, Spijkervet FK, Timens W, Timmer-Bosscha H, Sluiter WJ, van Buuren AH, Mulder NH, de Vries EG.
    Clin Cancer Res; 1999 Jun; 5(6):1363-8. PubMed ID: 10389920
    [Abstract] [Full Text] [Related]

  • 2. A new in vitro assay for quantitation of chemotherapy-induced mucositis.
    Wymenga AN, van der Graaf WT, Spijkervet FL, Timens W, Timmer-Bosscha H, Sluiter WJ, de Vries EG, Mulder NH.
    Br J Cancer; 1997 Jun; 76(8):1062-6. PubMed ID: 9376267
    [Abstract] [Full Text] [Related]

  • 3. Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.
    Ottosson S, Magnusson K, Hultborn R.
    Anticancer Res; 1999 Jun; 19(5C):4429-34. PubMed ID: 10650787
    [Abstract] [Full Text] [Related]

  • 4. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
    Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, Oh TY, Kim JW.
    Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
    [Abstract] [Full Text] [Related]

  • 5. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, Cesano A, Gayko U, Chen MG, Clarke S.
    J Clin Oncol; 2006 Nov 20; 24(33):5194-200. PubMed ID: 17075109
    [Abstract] [Full Text] [Related]

  • 6. Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors.
    Bhalla KN, Kumar GN, Walle UK, Ibrado AM, Javed T, Stuart RK, Reed C, Arbuck SG, Walle T.
    Clin Cancer Res; 1999 Jul 20; 5(7):1723-30. PubMed ID: 10430075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant.
    Meropol NJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK, Rothenberg ML, Redding SW, Serdar CM, Yao B, Heard R, Rosen LS.
    J Clin Oncol; 2003 Apr 15; 21(8):1452-8. PubMed ID: 12697866
    [Abstract] [Full Text] [Related]

  • 9. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.
    Demirer T, Ilhan O, Mandel NM, Arat M, Günel N, Celebi H, Ustün C, Akan H, Demirer S, Aydintuğ S, Uysal A, Koç H.
    Bone Marrow Transplant; 2000 Apr 15; 25(7):697-703. PubMed ID: 10745253
    [Abstract] [Full Text] [Related]

  • 10. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW, Long GD, Stockerl-Goldstein KE, Johnston LJ, Chao NJ, Negrin RS, Blume KG.
    Clin Cancer Res; 1999 Nov 15; 5(11):3411-8. PubMed ID: 10589752
    [Abstract] [Full Text] [Related]

  • 11. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov 15; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)].
    Fukazawa M, Kawaguchi H, Shigematsu H, Koga C, Mori E, Nishimura S, Nakamura Y, Satou S, Sawamura K, Kashiwaba K, Ohno S.
    Gan To Kagaku Ryoho; 2012 Mar 15; 39(3):395-8. PubMed ID: 22421766
    [Abstract] [Full Text] [Related]

  • 14. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
    Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, Demetri G, Levine J, Warren D, Arthur T, Reich E, Wheele C, Frei E, Ayash L.
    Bone Marrow Transplant; 2001 Feb 15; 27(3):269-78. PubMed ID: 11277174
    [Abstract] [Full Text] [Related]

  • 15. Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
    Kümmel S, Krocker J, Kohls A, Breitbach GP, Morack G, Budner M, Blohmer JU, Lichtenegger W, Elling D.
    Crit Rev Oncol Hematol; 2006 May 15; 58(2):166-75. PubMed ID: 16387512
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies.
    Lyass O, Hubert A, Gabizon AA.
    Clin Cancer Res; 2001 Oct 15; 7(10):3040-6. PubMed ID: 11595693
    [Abstract] [Full Text] [Related]

  • 17. The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
    De Placido S, Lauria R, Carlomagno C, Perrone F, De Laurentiis M, Gallo C, Martignetti A, Bellelli T, Limite G, Petrella G, Bianco AR.
    Int J Oncol; 1999 Aug 15; 15(2):339-46. PubMed ID: 10402245
    [Abstract] [Full Text] [Related]

  • 18. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial.
    Karthaus M, Rosenthal C, Huebner G, Paul H, Elser C, Hertenstein B, Krauter J, Scharmann T, Geissler RG, Heil G, Ganser A.
    Bone Marrow Transplant; 1998 Oct 15; 22(8):781-5. PubMed ID: 9827976
    [Abstract] [Full Text] [Related]

  • 19. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3.
    Sonis ST, Lindquist L, Van Vugt A, Stewart AA, Stam K, Qu GY, Iwata KK, Haley JD.
    Cancer Res; 1994 Mar 01; 54(5):1135-8. PubMed ID: 8118793
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies.
    Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S.
    Cancer; 2008 Apr 01; 112(7):1600-6. PubMed ID: 18300265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.